# The Establishment of Artificial RNA Cascade Circuits for Gene Regulation Based on Doxycycline-Induced Pre-mRNA Alternative Splicing

**Authors:** Guimin Dai, Jiawen Cheng, Weiran Liu, Xueli Yin, Yuanyuan Zhang

PMC · DOI: 10.3390/ijms26031163 · 2025-01-29

## TL;DR

This paper describes a new method using RNA switches to control gene expression in mammalian cells with doxycycline, enabling precise and reversible regulation.

## Contribution

The novel contribution is the development of RNA cascade circuits using doxycycline-induced pre-mRNA splicing for dynamic gene regulation.

## Key findings

- A chimeric intron module with RNA riboswitch and TetR aptamer was developed to regulate gene expression via doxycycline.
- Two contrasting switches (CTM and C2ITetR>4A) were created to reversibly control gene expression and tumor cell apoptosis.
- An RNA cascade system was designed to minimize crosstalk and enhance gene expression control using a single ligand.

## Abstract

This study developed an artificial chimeric intron module with an RNA riboswitch and TetR aptamer that were integrated into essential gene exons. Doxycycline can modulate Pre-mRNA alternative splicing, modify the exon reading frame, and dynamically regulate gene expression. By shifting the aptamer 2 base pair within the switch, we unexpectedly obtained the “on-switch” CTM and “off-switch” C2ITetR>4A, which possess thoroughly contrasting regulatory functions. The CTM module can conditionally induce tumor cell apoptosis and regulate genes reversibly and sustainably following doxycycline induction. We integrated the C2ITetR>4A/CTM switches with the L7Ae/k-turn module to create an intron-spliced double-switched RNA cascade system. The system can both activate and inhibit the splicing mechanism utilizing the same ligand to minimize crosstalk among aptamer switching elements, control target gene leakage, and enhance the dynamic range of gene expression. We analyzed numerous factors affecting Pre-mRNA splicing to identify the optimal equilibrium point for switch regulation. This will enable precise predictions of dynamic regulatory efficiency and the rational design of genetic modules, thereby providing a valuable instrument for mammalian synthetic biology.

## Linked entities

- **Proteins:** tetR (tetracycline resistance transcriptional repressor TetR), L7Ae (L7Ae, ribosomal protein 7Ae 60S large ribosomal subunit)
- **Chemicals:** doxorubicin (PubChem CID 31703), doxycycline (PubChem CID 54671203)
- **Diseases:** tumor (MONDO:0005070)

## Full-text entities

- **Genes:** HSF4 (heat shock transcription factor 4) [NCBI Gene 3299] {aka CTM, CTRCT5}
- **Diseases:** tumor (MESH:D009369)

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11817826/full.md

---
Source: https://tomesphere.com/paper/PMC11817826